Virginia Retirement Systems’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $295K | Sell |
36,200
-7,800
| -18% | -$63.5K | ﹤0.01% | 842 |
|
|
2025
Q1 | $345K | Buy |
+44,000
| New | +$345K | ﹤0.01% | 851 |
|
|
2023
Q3 | $449K | Sell |
25,000
-15,200
| -38% | -$273K | ﹤0.01% | 724 |
|
|
2023
Q2 | $816K | Sell |
40,200
-18,600
| -32% | -$378K | 0.01% | 602 |
|
|
2023
Q1 | $1.07M | Buy |
58,800
+9,200
| +19% | +$168K | 0.01% | 529 |
|
|
2022
Q4 | $1.03M | Buy |
49,600
+9,400
| +23% | +$194K | 0.01% | 602 |
|
|
2022
Q3 | $1.05M | Buy |
+40,200
| New | +$1.05M | 0.01% | 563 |
|
|
2021
Q3 | – | Sell |
-10,400
| Closed | -$286K | – | 1065 |
|
|
2021
Q2 | $286K | Buy |
10,400
+1,100
| +12% | +$30.3K | ﹤0.01% | 930 |
|
|
2021
Q1 | $261K | Buy |
9,300
+100
| +1% | +$2.81K | ﹤0.01% | 1026 |
|
|
2020
Q4 | $239K | Buy |
+9,200
| New | +$239K | ﹤0.01% | 1024 |
|